2019
DOI: 10.1007/s10014-019-00346-x
|View full text |Cite
|
Sign up to set email alerts
|

MN1 rearrangement in astroblastoma: study of eight cases and review of literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
35
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 16 publications
0
35
0
Order By: Relevance
“…With the advancement of gene identi cation technology, numerous speci c genes have been identi ed in astroblastomas. The most frequent gene alterations detected were MN1 mutation, gain of chromosome arm 20q and chromosome 19, loss of 9q, 10 and X [18][19][20]. These ndings suggested that astroblastomas represent a distinct entity with characteristic cytogenetic features that differ from those of ependymomas and astrocytomas.…”
Section: Discussionmentioning
confidence: 88%
“…With the advancement of gene identi cation technology, numerous speci c genes have been identi ed in astroblastomas. The most frequent gene alterations detected were MN1 mutation, gain of chromosome arm 20q and chromosome 19, loss of 9q, 10 and X [18][19][20]. These ndings suggested that astroblastomas represent a distinct entity with characteristic cytogenetic features that differ from those of ependymomas and astrocytomas.…”
Section: Discussionmentioning
confidence: 88%
“…rearranged tumors could be associated with a favorable prognosis and indolent course, our experience suggests a more aggressive clinical course 6,9. The majority of CNS-HGNET-MN1 tumors were initially classified as astroblastoma or ependymoma, however some were even diagnosed as PNET, suggesting initial therapies were highly heterogeneous.…”
mentioning
confidence: 78%
“…4 CNS HGNET-MN1 is a poorly defined entity with an indeterminant biological and clinical behavior rendering it very difficult to ascribe treatment recommendations. Although there have been only individual cases or small series, [5][6][7][8] there is a paucity of data to propose a standard therapy, primarily due to the rarity of the condition resulting in any individual center having a limited clinical experience. Herein, we describe our experience with the radiologic features, treatment, and outcome of an international cohort of CNS HGNET-MN1 tumors.…”
mentioning
confidence: 99%
“…[ 12 ] A case series reported a MN1 (meningioma 1 gene) rearrangement detected by Florescent in situ hybridization in five out of eight cases tested, which can be a potential confirmatory immunohistochemistry marker. [ 14 ]…”
Section: Discussionmentioning
confidence: 99%